Literature DB >> 20426422

Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis.

Timothy A Hill1, Anna Mariana, Christopher P Gordon, Luke R Odell, Mark J Robertson, Andrew B McGeachie, Ngoc Chau, James A Daniel, Nick N Gorgani, Phillip J Robinson, Adam McCluskey.   

Abstract

Herein we report the synthesis of discrete iminochromene ("iminodyn") libraries (14-38) as potential inhibitors of dynamin GTPase. Thirteen iminodyns were active (IC(50) values of 260 nM to 100 microM), with N,N-(ethane-1,2-diyl)bis(7,8-dihydroxy-2-iminochromene-3-carboxamide) (17), N,N-(ethane-1,2-diyl)bis(7,8-dihydroxy-2-iminochromene-3-carboxamide) (22), and N,N-(ethane-1,2-diyl)bis(7,8-dihydroxy-2-iminochromene-3-carboxamide) (23) (IC(50) values of 330 +/- 70, 450 +/- 50, and 260 +/- 80 nM, respectively) being the most potent. Five of the most potent iminodyns all inhibited dynamins I and II approximately equally. Iminodyn-22 displayed uncompetitive inhibition with respect to GTP. Selected iminodyns were evaluated for their ability to block receptor mediated endocytosis (RME, mediated by dynamin II) and synaptic vesicle endocytosis (SVE, mediated by dynamin I), with 17 showing no activity while 22 returned RME and SVE IC(50) values of 10.7 +/- 4.5 and 99.5 +/- 1.7 microM, respectively. The iminodyns reported herein represent a new chemical class of the first nanomolar potent dynamin inhibitors that are also effective endocytosis inhibitors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20426422     DOI: 10.1021/jm100119c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

1.  Analysis of synaptic vesicle endocytosis in synaptosomes by high-content screening.

Authors:  James A Daniel; Chandra S Malladi; Emma Kettle; Adam McCluskey; Phillip J Robinson
Journal:  Nat Protoc       Date:  2012-07-05       Impact factor: 13.491

2.  Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism.

Authors:  Callista B Harper; Sally Martin; Tam H Nguyen; Shari J Daniels; Nickolas A Lavidis; Michel R Popoff; Gordana Hadzic; Anna Mariana; Ngoc Chau; Adam McCluskey; Phillip J Robinson; Frederic A Meunier
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

3.  Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors.

Authors:  Ryan J Park; Hongying Shen; Lijuan Liu; Xinran Liu; Shawn M Ferguson; Pietro De Camilli
Journal:  J Cell Sci       Date:  2013-09-17       Impact factor: 5.285

4.  Synthesis of Dynole 34-2, Dynole 2-24 and Dyngo 4a for investigating dynamin GTPase.

Authors:  Mark J Robertson; Fiona M Deane; Phillip J Robinson; Adam McCluskey
Journal:  Nat Protoc       Date:  2014-03-20       Impact factor: 13.491

5.  The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity.

Authors:  Mark J Robertson; Gordana Hadzic; Joseph Ambrus; D Yuri Pomè; Emily Hyde; Ainslie Whiting; Anna Mariana; Lisa von Kleist; Ngoc Chau; Volker Haucke; Phillip J Robinson; Adam McCluskey
Journal:  ACS Med Chem Lett       Date:  2012-03-26       Impact factor: 4.345

6.  Dynamin regulates specific membrane fusion events necessary for acrosomal exocytosis in mouse spermatozoa.

Authors:  Andrew T Reid; Tessa Lord; Simone J Stanger; Shaun D Roman; Adam McCluskey; Phillip J Robinson; R John Aitken; Brett Nixon
Journal:  J Biol Chem       Date:  2012-09-12       Impact factor: 5.157

7.  Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis.

Authors:  Imran Khan; Brunilde Gril; Patricia S Steeg
Journal:  Cancer Res       Date:  2019-07-16       Impact factor: 12.701

8.  Visualizing Coronavirus Entry into Cells.

Authors:  Aleksandra Milewska; Katarzyna Owczarek; Artur Szczepanski; Krzysztof Pyrc
Journal:  Methods Mol Biol       Date:  2020

9.  Dynamin inhibitors induce caspase-mediated apoptosis following cytokinesis failure in human cancer cells and this is blocked by Bcl-2 overexpression.

Authors:  Sanket Joshi; Antony W Braithwaite; Phillip J Robinson; Megan Chircop
Journal:  Mol Cancer       Date:  2011-06-28       Impact factor: 27.401

10.  Dynamin inhibitors impair endocytosis and mitogenic signaling of PDGF.

Authors:  Łukasz Sadowski; Kamil Jastrzębski; Yannis Kalaidzidis; Carl-Henrik Heldin; Carina Hellberg; Marta Miaczynska
Journal:  Traffic       Date:  2013-03-12       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.